These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10877424)

  • 1. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization.
    DeMeritt JS; Elmasri FF; Esposito MP; Rosenberg GS
    J Vasc Interv Radiol; 2000 Jun; 11(6):767-70. PubMed ID: 10877424
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia in the Setting of Bladder Calculi.
    Kim JI; Brader R; Viprakasit DP; Isaacson AJ
    J Vasc Interv Radiol; 2017 Feb; 28(2):306-308. PubMed ID: 28110763
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study".
    Bilhim T
    J Vasc Interv Radiol; 2014 Apr; 25(4):659-60. PubMed ID: 24674226
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study.
    Kisilevzky N; Garcia-Monaco R
    J Vasc Interv Radiol; 2014 Apr; 25(4):658-9. PubMed ID: 24674225
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J
    J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic arterial embolization to treat benign prostatic hyperplasia.
    Pisco JM; Pinheiro LC; Bilhim T; Duarte M; Mendes JR; Oliveira AG
    J Vasc Interv Radiol; 2011 Jan; 22(1):11-9; quiz 20. PubMed ID: 21195898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH.
    Moreira AM; de Assis AM; Carnevale FC; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1490-1500. PubMed ID: 28795212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate artery embolisation for benign prostatic hyperplasia.
    Challacombe B; Sabharwal T
    BMJ; 2018 Jun; 361():k2537. PubMed ID: 29921580
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia.
    Hwang JH; Park SW; Chang IS; Jung SI; Jeon HJ; Lho YS; Kim HG; Paick SH; Park HK
    Biomed Res Int; 2017; 2017():8732351. PubMed ID: 28717651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results.
    Pisco J; Campos Pinheiro L; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Vaz Santos V; Oliveira AG
    Radiology; 2013 Feb; 266(2):668-77. PubMed ID: 23204546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive bladder cooling reflex in patients with bladder outlet obstruction due to benign prostatic hyperplasia.
    Gotoh M; Yoshikawa Y; Kondo AS; Kondo A; Ono Y; Ohshima S
    World J Urol; 1999 Apr; 17(2):126-30. PubMed ID: 10367373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Artery Embolization in Patients With Acute Urinary Retention.
    Kenny AG; Pellerin O; Amouyal G; Desgranchamps F; Méria P; De Gouvello A; Dariane C; Déan C; Pereira H; Thiounn N; Sapoval M
    Am J Med; 2019 Nov; 132(11):e786-e790. PubMed ID: 31103644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study.
    Kurbatov D; Russo GI; Lepetukhin A; Dubsky S; Sitkin I; Morgia G; Rozhivanov R; Cimino S; Sansalone S
    Urology; 2014 Aug; 84(2):400-4. PubMed ID: 24929948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transrectal microwave hyperthermia for benign prostatic hyperplasia: long-term clinical, pathological and ultrastructural patterns.
    Montorsi F; Galli L; Guazzoni G; Colombo R; Bulfamante G; Barbieri L; Matozzo V; Grazioli V; Rigatti P
    J Urol; 1992 Aug; 148(2 Pt 1):321-5. PubMed ID: 1378906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.